<?xml version="1.0" encoding="UTF-8"?>
<p>On 10 March 2020, Coregiani 
 <italic>et al.</italic> reported a systematic review of CQâ€™s safety and efficacy in COVID-19.
 <sup>
  <xref rid="bibr55-2049936120947517" ref-type="bibr">55</xref>
 </sup> After going through six different studies, they could only identify promising preclinical studies but non-conclusive clinical evidence. They recommended that the clinical use of CQ/HCQ must adhere to the Monitored Emergency Use of Unregistered Interventions (MEURI) framework, or the WHO ethical guidelines for the clinical trials, and expressed the urgent need for high-quality clinical trials to provide conclusive evidence.
</p>
